Shareholders meeting

30th July, 2026 BSE Limited National Stock Exchange of India Limited P.J. Towers, Dalal Street, Fort, Exchange Plaza, Bandra-Kurla Complex, Mumbai- 400 001 Bandra (East), Mumbai – 400 051 BSE scrip code: 543635 NSE symbol: PPLPHARMA Sub: Proceedings and Voting Results of the 6th Annual General Meeting (‘AGM’) of Piramal Pharma Limited (‘the Company’) Dear Sir / Madam, This is to inform that the 6th AGM of the Members of the Company was held today, Thursday, 30th July, 2026 at 3:00 p.m. (IST) through Video Conferencing / Other Audio Visual Means for transacting the business(es) mentioned in the Notice dated 5th June, 2026 convening the AGM (‘Notice of the AGM’). All the resolutions proposed in the Notice of the AGM have been passed with requisite majority. In this regard, please find enclosed the following: 1. Summary of the proceedings of the AGM, pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI Listing Regulations’), attached as Annexure-1; and 2. Consolidated Report of the Scrutinizer, pursuant to Section 108 of the Companies Act, 2013 read with Rule 20 of the Companies (Management and Administration) Rules, 2014, along with voting results of the business transacted at the AGM, pursuant to Regulation 44(3) of the SEBI Listing Regulations, attached as Annexure-2. This is for your information and records. Thank you. Yours truly, For Piramal Pharma Limited Maneesh Sharma Company Secretary & Compliance Officer Encl: a/a Piramal Pharma Limited CIN: L24297MH2020PLC338592 Registered Office: Ananta Building, Piramal Corporate Park, Opp. Fire Brigade, Kamani Junction, LBS Marg, Kurla (West), Mumbai – 400070, Maharashtra, India Tel No. +91 22 3802 3000 / 4000; Email Id: shareholders.ppl@piramal.com www.piramalpharma.com Annexure-1 Summary of proceedings of the 6th Annual General Meeting of Piramal Pharma Limited held on 30th July, 2026 The 6th Annual General Meeting (‘AGM’) of Piramal Pharma Limited (‘the Company’) was held today, Thursday, 30th July, 2026 at 3:00 p.m. (IST) through Video Conferencing (‘VC’)/ Other Audio Visual Means (‘OAVM’) in accordance with circulars issued by Ministry of Corporate Affairs and the Securities and Exchange Board of India (‘SEBI’). Ms. Nandini Piramal, Chairperson of the Company, chaired the meeting. The requisite quorum being present, the Chairperson called the Meeting to order. The Chairperson introduced all the Board Members along with the Chairpersons of the Audit Committee, Stakeholders Relationship Committee, Nomination and Remuneration Committee, who were present at the Meeting. The Chairperson informed that, apart from the Board Members, the key executives and representatives of the Auditors were also present at the AGM. The Members were informed that live proceedings of the AGM were being webcast live on the e-voting website of National Securities Depository Limited (‘NSDL’). With the consent of the Members present, the Notice convening the 6th AGM was taken as read. The Members were informed that as there were no qualifications in the Audit Report, the notice was not required to be read. The Members were also informed that the relevant Statutory Registers and documents were available for inspection electronically during the Meeting. The Members were also informed that in accordance with the provisions of Section 108 of the Companies Act, 2013 (‘the Act’) read with Rule 20 of the Companies (Management and Administration) Rules, 2014 and Regulation 44 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Company had provided remote e-voting facility to its Members for casting of the votes through electronic means. The remote e-voting commenced at 9:00 a.m. on Monday, 27th July, 2026 and ended at 5:00 p.m. on Wednesday, 29th July, 2026. The facility for e-voting was also made available during the AGM, in accordance with the provisions on e-voting framed under the Act, for Members who had not cast their vote through remote e-voting. The Members were informed that Mr. Bhaskar Upadhyay, Practising Company Secretary, failing him Mr. Bharat R. Upadhyay, Practising Company Secretary of N L Bhatia & Associates, Practising Company Secretaries, was appointed as the Scrutinizer to scrutinize the process of remote e-voting and e-voting during the AGM. Piramal Pharma Limited CIN: L24297MH2020PLC338592 Registered Office: Ananta Building, Piramal Corporate Park, Opp. Fire Brigade, Kamani Junction, LBS Marg, Kurla (West), Mumbai – 400070, Maharashtra, India Tel No. +91 22 3802 3000 / 4000; Email Id: shareholders.ppl@piramal.com www.piramalpharma.com The Chairperson then apprised the Members regarding the performance of the Company and key highlights of FY 2025-26. Thereafter, the following items of business as set out in the Notice convening the 6th AGM were transacted, and the resolutions relating thereto were put to vote and duly passed by the Members with the requisite majority: No. Resolutions Type of resolution Ordinary Business: 1. Adoption of Audited Financial Statements (Standalone and Ordinary Consolidated) of the Company for the financial year ended 31st March, 2026 and the Reports of the Board of Directors and Auditors thereon 2. Re-appointment of Mr. Peter DeYoung (DIN: 07152550), who Ordinary retires by rotation and being eligible, offers himself for re- appointment 3. Re-appointment of Ms. Nathalie Leitch (DIN: 09557042), who Ordinary retires by rotation and being eligible, offers herself for re- appointment Special Business: 4. Re-appointment of Mr. Peter DeYoung (DIN: 07152550) as Special Whole-Time Director, designated as Executive Director of the Company 5. Re-appointment of Ms. Nandini Piramal (DIN: 00286092) as Special Whole-Time Director, designated as Executive Director and Chairperson of the Company 6. Re-appointment of Mr. Sridhar Gorthi (DIN: 00035824) as an Special Independent Director of the Company 7. Re-appointment of Mr. Peter Stevenson (DIN: 09544706) as Special an Independent Director of the Company 8. Ratification of remuneration payable to Cost Auditors for the Ordinary Financial Year 2026-27 9. Issue of Non-Convertible Debentures on Private Placement Special Basis 10. Creation of pledge or any other security or encumbrance over the Special shareholding of the Company in its material subsidiaries and/ or the assets of such material subsidiaries, and enabling approval for related disposal in the event of enforcement of such pledge, security or encumbrance The Chairperson then invited the Members who had registered themselves as speakers to express their views, ask questions and seek clarifications on the operations and financial performance of the Company and the resolutions proposed. The Chairperson responded to the queries raised by the Members. Piramal Pharma Limited CIN: L24297MH2020PLC338592 Registered Office: Ananta Building, Piramal Corporate Park, Opp. Fire Brigade, Kamani Junction, LBS Marg, Kurla (West), Mumbai – 400070, Maharashtra, India Tel No. +91 22 3802 3000 / 4000; Email Id: shareholders.ppl@piramal.com www.piramalpharma.com The Members were informed that the voting results along with the consolidated report of the Scrutinizer would be disseminated to the Stock Exchanges and would also be placed on the website of the Company and NSDL, within the prescribed statutory timelines. The Meeting concluded at 4:26 p.m., after remaining open for 15 minutes to enable completion of the e-voting process. Piramal Pharma Limited CIN: L24297MH2020PLC338592 Registered Office: Ananta Building, Piramal Corporate Park, Opp. Fire Brigade, Kamani Junction, LBS Marg, Kurla (West), Mumbai – 400070, Maharashtra, India Tel No. +91 22 3802 3000 / 4000; Email Id: shareholders.ppl@piramal.com www.piramalpharma.com Annexure-2 Tel. : 91-022-25100718 NL BHATIA & ASSOCIATES Tel. : 91-022-2510 0698 E-mail : navnitlb@hotmail.com PRACTISING COMPANY SECRETARIES brupadhyay@hotmail.com Website: www.nlba.in Scrutinizer's Repo [Showing first 8,000 characters — download PDF for full document]